A Study of Ivonescimab in First-Line ES-SCLC
A Study of Ivonescimab in First-Line ES-SCLC
Recruiting · NCT07245446 · Registry updated 2025-11-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Ivonescimab in First-Line ES-SCLC | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm, small cell lung carcinoma | Recruiting | Phase 2 | 2025-11-24 | NCT07245446 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Akeso | 89 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cancer Hospital Chinese Academy of Medical Sciences | Beijing | China | 4 |
| Shanghai Pulmonary Hospital Affiliated to Tongji University | Shanghai | China | 1 |
| The First Affiliated Hospital of Xi'an Jiaotong University | Xi'an | China | 11 |